Effect of Yoga Breathing Exercises Versus Aerobic Exercise on Hematological Parameters

Sponsor
Shokry Mahmoud Youssef Mohamed (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05949437
Collaborator
(none)
60
1
2
5.5
11

Study Details

Study Description

Brief Summary

Is there effect of yoga breathing exercises versus aerobic exercise on hematological parameters in iron deficiency anemic females?

The purpose of the study is to investigate the effect of yoga breathing exercises versus aerobic exercise on hematological parameters in iron deficiency anemic females

Condition or Disease Intervention/Treatment Phase
  • Other: Yuga
  • Other: Aerobic exercises
N/A

Detailed Description

60 patients with iron deficiency anemia and will receive medical treatment of anemia and Dietary advice for 12 weeks . thirty patient from the 60 patients will receive yoga therapy and 50 minutes yoga therapy 6 days a week for 12 weeks while the other 30 patients will receive aerobic exercise for 12 weeks

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Effect of Yoga Breathing Exercises Versus Aerobic Exercise on Hematological Parameters in Iron Deficiency Anemic Females
Actual Study Start Date :
Jul 17, 2023
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group (I)

consists of 30 patients with iron deficiency anemia and will receive medical treatment of anemia, Dietary advices and 50 minutes yoga therapy 6 days a week for 12 weeks

Other: Yuga
Traditional yoga body posture for 15 minutes, yoga breathing exercises for 30 minutes and meditation for 5 minutes for 12 weeks

Other: Group (II)

consists of 30 patients with iron deficiency anemia and will receive medical treatment for anemia, Diet advices and 30 minutes of aerobic exercises in form of treadmill according to the target exercise heart rate for 12 weeks.

Other: Aerobic exercises
in form of treadmill according to the target exercise heart rate for 12 weeks

Outcome Measures

Primary Outcome Measures

  1. serum iron level [it will be measured after 12 weeks]

    it will be measured in serum from complete blood picture. Reference range from 50 till 212 ug/dl. Number of participants are 60 females.

  2. ferritin level [it will be measured after 12 weeks]

    it will be measured in serum from iron profile. Reference range from 10 till 158 ng/ml. Number of participants are 60 females.

  3. iron binding capacity level [it will be measured after 12 weeks]

    it will be measured in serum from iron profile. Reference range from 250 till 400 ug/dl. Number of participants are 60 females.

  4. count of red blood cells [it will be measured after 12 weeks]

    it will be measured in serum from complete blood picture. Reference range from 3.80 till 4.80 million cell/cmm. Number of participants are 60 females.

  5. Hemoglobin level [it will be measured after 12 weeks]

    it will be measured in serum from complete blood . picture. Reference range from 12 till 15 g/dl. Number of participants are 60 females.

  6. hematocrite level [it will be measured after 12 weeks]

    it will be measured in serum from complete blood picture. Reference range from 36% till 45%. Number of participants are 60 females.

  7. lymphocytes level [it will be measured after 12 weeks]

    it will be measured in serum from differential white cell count. Reference range absolute from 1000 till 4000 and relative from 20% till 45%. Number of participants are 60 females.

Secondary Outcome Measures

  1. six minute walking distance [it will be measured after 12 weeks]

    The six minute walking distance is measured using six Minute Walk Test which is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity. The tools are used include 30 meters corridor,2 cones,stopwatch,chair,mechanical lap counter and sphygmomanometer Number of participants are 60 females.

  2. The fatigue severity scale(FSS) [it will be measured after 12 weeks]

    The FSS questionnaire contains nine statements that rate the severity of your fatigue symptoms. Read each statement and circle a number from 1 to 7, based on how accurately it reflects your condition during the past week and the extent to which you agree or disagree that the statement applies to you. A total score of less than 36 suggests that you may not be suffering from fatigue. A total score of 36 or more suggests that you may need further evaluation by a physician. Number of participants are 60 females.

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Sixty female patients referred with iron deficiency anemia

  2. Their age will be ranged from 30-40 years old.

  3. All patients have a history of anemia.

  4. All patients should be medically stable.

  5. The body mass index (BMI) ranged from 25:29.9 Kg/m2

  6. Number of parity not exceed 3 times.

  7. Period of menses from 3-5 days

Exclusion Criteria:
  1. Patients with cognitive impairments.

  2. All types of anemia except iron deficiency anemia

  3. patients with hearing problems.

  4. patients with Diabetes, Hypertension.

  5. Patients with Musculoskeletal, Neurological, Cardiovascular and Respiratory problems

  6. patients with mental problems.

Contacts and Locations

Locations

Site City State Country Postal Code
1 October 6 university Giza Egypt

Sponsors and Collaborators

  • Shokry Mahmoud Youssef Mohamed

Investigators

  • Principal Investigator: shoukry MA youssef, ass lecturer, 6 october University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shokry Mahmoud Youssef Mohamed, Assistant lecturer of physical therapy for Internal Medicine and Geriatrics, October 6 University
ClinicalTrials.gov Identifier:
NCT05949437
Other Study ID Numbers:
  • P.T.REC/012/004556
First Posted:
Jul 18, 2023
Last Update Posted:
Jul 18, 2023
Last Verified:
Jul 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 18, 2023